Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments.

Aricò E, Castiello L, Urbani F, Rizza P, Panelli MC, Wang E, Marincola FM, Belardelli F.

J Transl Med. 2011 May 17;9:67. doi: 10.1186/1479-5876-9-67.

2.

Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.

Haroon F, Drögemüller K, Händel U, Brunn A, Reinhold D, Nishanth G, Mueller W, Trautwein C, Ernst M, Deckert M, Schlüter D.

J Immunol. 2011 Jun 1;186(11):6521-31. doi: 10.4049/jimmunol.1001135. Epub 2011 Apr 22.

3.

Astrocytes in the tempest of multiple sclerosis.

Miljković D, Timotijević G, Mostarica Stojković M.

FEBS Lett. 2011 Dec 1;585(23):3781-8. doi: 10.1016/j.febslet.2011.03.047. Epub 2011 Mar 31. Review.

4.

Regulation and functions of the IL-10 family of cytokines in inflammation and disease.

Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG.

Annu Rev Immunol. 2011;29:71-109. doi: 10.1146/annurev-immunol-031210-101312. Review.

PMID:
21166540
5.

TNFα and IFNγ synergistically enhance transcriptional activation of CXCL10 in human airway smooth muscle cells via STAT-1, NF-κB, and the transcriptional coactivator CREB-binding protein.

Clarke DL, Clifford RL, Jindarat S, Proud D, Pang L, Belvisi M, Knox AJ.

J Biol Chem. 2010 Sep 17;285(38):29101-10. doi: 10.1074/jbc.M109.0999952.

6.

Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H, Liu L, Qian W, Ransohoff RM, Bergmann C, Stohlman S, Tuohy VK, Li X.

Immunity. 2010 Mar 26;32(3):414-25. doi: 10.1016/j.immuni.2010.03.004. Epub 2010 Mar 18.

7.

Empowering T helper 17 cells in autoimmunity.

Veldhoen M, Seddon B.

Nat Med. 2010 Feb;16(2):166-8. doi: 10.1038/nm0210-166. No abstract available.

PMID:
20134470
8.

Astrocytes: biology and pathology.

Sofroniew MV, Vinters HV.

Acta Neuropathol. 2010 Jan;119(1):7-35. doi: 10.1007/s00401-009-0619-8. Epub 2009 Dec 10. Review.

9.

Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Hu X, Ivashkiv LB.

Immunity. 2009 Oct 16;31(4):539-50. doi: 10.1016/j.immuni.2009.09.002. Review.

10.

Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.

Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV.

J Neurosci. 2009 Sep 16;29(37):11511-22. doi: 10.1523/JNEUROSCI.1514-09.2009.

11.

SOCS1 and SOCS3 in the control of CNS immunity.

Baker BJ, Akhtar LN, Benveniste EN.

Trends Immunol. 2009 Aug;30(8):392-400. doi: 10.1016/j.it.2009.07.001. Epub 2009 Jul 28. Review.

12.

Autoimmune T cell responses in the central nervous system.

Goverman J.

Nat Rev Immunol. 2009 Jun;9(6):393-407. doi: 10.1038/nri2550. Review.

13.

Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation.

Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR.

J Immunol. 2009 Mar 1;182(5):2628-40. doi: 10.4049/jimmunol.0802954.

14.

Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis.

Lees JR, Golumbek PT, Sim J, Dorsey D, Russell JH.

J Exp Med. 2008 Oct 27;205(11):2633-42. doi: 10.1084/jem.20080155. Epub 2008 Oct 13.

15.

How interferon-gamma keeps autoimmune diseases in check.

Kelchtermans H, Billiau A, Matthys P.

Trends Immunol. 2008 Oct;29(10):479-86. doi: 10.1016/j.it.2008.07.002. Epub 2008 Sep 3. Review.

PMID:
18775671
16.

The immunology of multiple sclerosis.

Bar-Or A.

Semin Neurol. 2008 Feb;28(1):29-45. doi: 10.1055/s-2007-1019124. Review.

PMID:
18256985
17.

Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells.

Fitzgerald DC, Zhang GX, El-Behi M, Fonseca-Kelly Z, Li H, Yu S, Saris CJ, Gran B, Ciric B, Rostami A.

Nat Immunol. 2007 Dec;8(12):1372-9. Epub 2007 Nov 11. Erratum in: Nat Immunol. 2008 Jan;9(1):105.

PMID:
17994023
18.

Multiple sclerosis: a complicated picture of autoimmunity.

McFarland HF, Martin R.

Nat Immunol. 2007 Sep;8(9):913-9. Review.

PMID:
17712344
19.

Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.

Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A.

J Immunol. 2007 Sep 1;179(5):3268-75.

20.

Astrocytes--friends or foes in multiple sclerosis?

Williams A, Piaton G, Lubetzki C.

Glia. 2007 Oct;55(13):1300-12. Review.

PMID:
17626262

Supplemental Content

Support Center